Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori is a Gram-negative, microaerophilic bacterium that colonizes the human gastric mucosa, where its cell wall and periplasmic structures are essential for survival in the extreme acidic environment (Source: StatPearls). The cell envelope consists of an inner membrane, a thin peptidoglycan layer, and an outer membrane, with the periplasmic space housing critical enzymes like urease that neutralize stomach acid by producing ammonia (Source: Nature Reviews Microbiology). These structures are the primary targets for several first-line antibiotics, most notably amoxicillin, which inhibits the penicillin-binding proteins (PBPs) required for peptidoglycan synthesis (Source: PubMed). Disruption of the cell wall leads to bacterial lysis, making it a cornerstone of therapy for peptic ulcers and gastric cancer prevention (Source: NIH). Additionally, the periplasmic components are involved in the transport of nutrients and the assembly of the Type IV secretion system, which is vital for the injection of virulence factors into host cells (Source: PubMed). The unique composition of the H. pylori cell wall, including its modified lipopolysaccharides, also plays a significant role in immune evasion and chronic infection (Source: Nature Reviews Microbiology). Understanding these structures is crucial for overcoming the rising challenge of antibiotic resistance in H. pylori infections (Source: WHO).
Inhibition of peptidoglycan cross-linking via binding to penicillin-binding proteins (PBPs) and direct bactericidal effects through cell wall disruption.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori cell wall and periplasmic structures.